Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-08-061009
Filing Date
2008-11-04
Accepted
2008-11-04 16:41:22
Documents
1
Period of Report
2008-10-10

Document Format Files

Seq Description Document Type Size
1 v130470_ex.html 3  
1 v130470_ex.xml 3 2954
  Complete submission text file 0001144204-08-061009.txt   4753
Mailing Address 20 KINGSBRIDGE RD PISCATAWAY NJ 08854
Business Address 40 JACKIE DR LONG VALLEY NJ 07853
ZUERBLIS KENNETH J (Reporting) CIK: 0001007923 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51310 | Film No.: 081161325

Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Issuer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations